In the three months since the virus began its deadly spread, China, Europe and the United States have all set off at a sprint to become the first to produce a vaccine. President Donald Trump has talked in meetings with pharmaceutical executives about making sure a vaccine is produced on American soil, to assure the US controls its supplies. His firm is working with Eli Lilly and Johnson & Johnson in the United States, Roche and Takeda in Japan. But it is governments that get to decide how a vaccine is approved, and where it can be sold. Mindful of those dangers, though, several European governments and nonprofit groups have already taken steps to prevent either the United States or China from capturing a monopoly on a potential vaccine against the coronavirus.

Source: bd News24 March 20, 2020 05:37 UTC